MLND: Millendo Therapeutics, Inc. - Summary | Jitta

Millendo Therapeutics, Inc.

NASDAQ:MLND

Notice
Stock data is unavailable or the company’s delisted.
Price
$15.90
Loss Chance
58.4%
0.54JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (9)
Recent Business Performance (33)
Financial Strength (21)
Return to Shareholders (0)
Competitive Advantage (6)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
CapExVery High
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.54
100.00%
2.43
422.26%
2.43
422.26%
6.89
52.20%
COMPANY DESCRIPTION
As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.